This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,459.35 Firm Fixed Price Delivery Order contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. These contract awards demonstrate AmerisourceBergen's extensive capabilities in supplying critical medical commodities, including specialty medications, across multiple federal agencies and healthcare programs.
Generated 3/18/25, 9:50 AM